UNITED CAPITAL FINANCIAL ADVISORS, LLC - FIVE PRIME THERAPEUTICS INC ownership

FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 113 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 469.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
UNITED CAPITAL FINANCIAL ADVISORS, LLC ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$59,000
-23.4%
12,6010.0%0.00%
-100.0%
Q2 2020$77,000
+165.5%
12,6010.0%0.00%
Q1 2020$29,000
-50.0%
12,6010.0%0.00%
Q4 2019$58,000
+18.4%
12,6010.0%0.00%
Q3 2019$49,000
-35.5%
12,6010.0%0.00%
Q2 2019$76,000
-56.1%
12,6010.0%0.00%
-100.0%
Q1 2019$173,000
+53.1%
12,6010.0%0.00%0.0%
Q4 2018$113,000
-35.8%
12,6010.0%0.00%0.0%
Q3 2018$176,000
-11.6%
12,6010.0%0.00%0.0%
Q2 2018$199,000
-8.3%
12,601
-0.1%
0.00%
-50.0%
Q1 2018$217,000
-21.4%
12,610
+0.1%
0.00%0.0%
Q4 2017$276,000
-46.5%
12,6010.0%0.00%
-50.0%
Q3 2017$516,000
+36.1%
12,6010.0%0.00%
+33.3%
Q2 2017$379,000
-16.9%
12,6010.0%0.00%
-25.0%
Q1 2017$456,000
-27.7%
12,6010.0%0.00%
-33.3%
Q4 2016$631,00012,6010.01%
Other shareholders
FIVE PRIME THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Eventide Asset Management 601,000$24,587,0001.39%
HealthCor Management, L.P. 1,010,930$41,357,0001.39%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 86,500$3,535,0001.38%
PURA VIDA INVESTMENTS, LLC 75,000$3,068,0000.90%
BB BIOTECH AG 777,500$31,808,0000.88%
AWM Investment Company, Inc. 100,000$4,091,0000.71%
Granite Point Capital Management, L.P. 50,000$2,046,0000.43%
Rock Springs Capital Management LP 217,700$8,906,0000.41%
Crestline Management, LP 50,919$2,083,0000.29%
ADAGE CAPITAL PARTNERS GP, L.L.C. 2,432,700$99,522,0000.24%
View complete list of FIVE PRIME THERAPEUTICS INC shareholders